Now accepting early access partners

Validation that moves
at the speed of science.

EVOLV | The Validation Factory

The first AI-native Computer System Validation platform built for GAMP 5, 21 CFR Part 11, and FDA QMSR. Generate compliant URS, automate risk assessment, and govern AI model changes — in minutes, not months.

Request Early Access ▶ Try Live Demo
GAMP 5 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 2025 GMP Annex 11 EU GMP

The Problem

CSV validation still runs on
spreadsheets and email chains.

Life sciences teams spend months on documentation that should take days. Regulatory guidance has changed. Most platforms haven't.

📋

Weeks to generate a URS

Requirements written manually in Word, reviewed in meetings, rewritten after audit findings. No regulatory traceability. No version control. Just documents.

⚠️

Regulations change. VMPs don't.

FDA's QMSR replaced the QSR on February 2, 2026. The PCCP final guidance landed August 2025. Most validation plans still cite rules that no longer exist.

🤖

AI in GxP with no governance

Drug interaction predictors and defect classifiers are being deployed with no PCCP, no change control, no audit trail. FDA inspectors are starting to notice.

The Platform

One platform.
The entire validation lifecycle.

From first requirement to post-market governance — every step compliant, auditable, and powered by AI that knows GAMP 5.

📄

Validation Factory

Generate GAMP 5-compliant URS from plain English. SMART refinement, PCCP verification, UR/FR decomposition, CSA test scripts, and PDF export with e-signature — in one guided workflow. What took days takes minutes.

URS Generation SMART Refinement UR/FR Decomposition CSA Test Scripts PDF + E-Signature
🔄

Change Control

ServiceNow change requests cross-referenced against your system portfolio in real time. GxP classification, GAMP-aware risk calculation using Severity × Occurrence × Detectability, and automatic revalidation flags. No spreadsheet required.

ServiceNow Integration GxP Classification GAMP Risk Matrix Revalidation Flags
🤖

AI Model Governance

Validated AI models treated as GAMP Category 5 assets. PCCP-aware change assessment aligned to FDA final guidance August 2025. Human-in-the-loop approval queue with 21 CFR Part 11 compliant audit trail.

PCCP Assessment HITL Governance FDA Aug 2025 21 CFR Part 11
📊

Portfolio Dashboard

Every system, every site, every phase — one view. RAG status, action items, regulatory due dates. Register new systems with GxP classification and track their full validation journey from plan to monitor. Built for QA Heads and CTOs.

RAG Status System Registry Lifecycle Tracking Multi-Site

See It In Action

Watch EVOLV handle in 4 minutes
what takes your team weeks.

Three real workflows. No voiceover scripts. No slides. Just the platform doing what it's built to do.

Demo 01

Portfolio Dashboard

Your entire validated system landscape — GAMP category, GxP status, risk level, revalidation due dates — in one view. Built for QA Heads and CTOs who need portfolio-wide compliance visibility instantly..

Demo 02

Change Control & GxP Classification

ServiceNow CR received → portfolio cross-reference → GAMP risk calculation → revalidation decision. Automatic.

Demo 03

AI Model Governance

AI model change in a validated system → PCCP assessment → Governance Hub → human-in-the-loop approval → 21 CFR Part 11 audit trail. Built for FDA's final guidance (Aug 2025).

Try the Validation Factory — live, right now.

Generate a real GAMP 5-compliant URS from your own requirement. No login required.

▶ Open Live Demo

Built For

EVOLV speaks the language
of regulated industries.

Whether you're defending a validation package in an inspection or governing 150 systems across 25 sites — EVOLV gives you the records to back it up.

🧪 QA Head · CSV Manager

Stop writing in Word. Start validating.

EVOLV generates, verifies, and manages your entire validation portfolio with a complete audit trail FDA inspectors can review on the spot.

  • URS from plain English in minutes
  • SMART requirements, auto-verified against GAMP 5
  • Full lifecycle tracking — Plan to Monitor
  • Audit-ready PDFs with e-signature

📋 VP Regulatory Affairs

FDA updated the rules. EVOLV already knows.

QMSR is mandatory. PCCP guidance is final. EVOLV cites the right regulations, routes the right changes, and produces the records you need when an inspector walks in.

  • Aligned to FDA PCCP Guidance Aug 18, 2025
  • 21 CFR Part 820 QMSR / ISO 13485:2016
  • SHA-256 tamper-evident audit trail
  • 21 CFR Part 11 electronic records

💻 CTO · CDO

Your AI models are GAMP Cat 5 assets.

EVOLV gives you the governance infrastructure to deploy AI in GxP contexts without regulatory exposure — with a full HITL approval layer and immutable decision records.

  • AI model registry with version history
  • PCCP-aware change assessment
  • Human-in-the-loop governance hub
  • Portfolio-wide RAG visibility

Regulatory Coverage

GAMP 5 (2nd Edition) 21 CFR Part 11 21 CFR Part 820 QMSR ISO 13485:2016 FDA PCCP Guidance Aug 18, 2025 GMP Annex 11 EU GMP GLP ISO 17025 GDPR 21 CFR Part 820.35 QMSR FDA CSA Guidance 2022

Early Access

Join our first cohort of life sciences partners.

We're working with a small group of pharma and biotech companies before general availability. Early access partners get priority onboarding, direct access to the founding team, and founding-tier pricing locked in permanently.

🔒  We'll respond within 1 business day. Your information is never shared.

How EvoLV Supports Medical Device Startups in California: A Community-Centric Approach

Jul 15, 2025

Empowering Innovation in Medical Technology

California is a hotbed for innovation, particularly in the medical device industry. One company that stands out in fostering this growth is EvoLV. By adopting a community-centric approach, EvoLV has created a robust support system for medical device startups, ensuring they not only survive but thrive in this competitive landscape.

At the core of EvoLV's mission is the belief that collaboration and community are key to driving technological advancement. This philosophy is reflected in their comprehensive support structure, which encompasses everything from mentorship to funding opportunities.

medical technology

A Network of Mentorship and Expertise

One of the most significant ways EvoLV supports startups is through its extensive mentorship network. They connect budding entrepreneurs with seasoned professionals who have a wealth of experience in the medical device field. These mentors provide invaluable guidance on product development, regulatory compliance, and market strategies.

Such mentorship not only helps startups avoid common pitfalls but also accelerates their journey from concept to market-ready product. By learning from experts who have navigated the industry successfully, startups can refine their processes and enhance their innovations.

Access to Funding and Resources

EvoLV understands that financial backing is crucial for any startup's success. They have established partnerships with venture capitalists and angel investors who are eager to invest in promising medical device technologies. This financial support allows startups to focus on innovation without the constant worry of funding constraints.

startup funding

In addition to financial resources, EvoLV provides access to cutting-edge technology and facilities. Startups can utilize state-of-the-art labs and equipment, ensuring they have the tools needed to develop high-quality, reliable medical devices.

Building a Collaborative Community

EvoLV fosters a vibrant community where startups can collaborate and share ideas. Regular workshops, seminars, and networking events are organized to bring together entrepreneurs, investors, and industry experts. These gatherings offer a platform for discussing new trends, challenges, and opportunities within the medical device sector.

Through this collaborative environment, startups can form strategic partnerships that enhance their capabilities and open new avenues for growth. The sense of community instilled by EvoLV encourages a culture of knowledge sharing and mutual support.

community collaboration

Driving Regulatory Compliance

Navigating the complex regulatory landscape is often a daunting task for medical device startups. EvoLV simplifies this process by providing expert advice on regulatory requirements and compliance standards. They work closely with startups to ensure their products meet all necessary guidelines before entering the market.

This proactive approach not only helps startups avoid costly delays but also enhances the credibility of their products in the eyes of potential customers and investors.

The Impact of EvoLV's Community-Centric Model

The community-centric model embraced by EvoLV has made a significant impact on the medical device startup ecosystem in California. By providing mentorship, funding, resources, and a collaborative environment, they have enabled numerous startups to turn innovative ideas into successful products.

EvoLV's approach demonstrates that when startups are supported by a strong community and access to expertise, they can overcome challenges more effectively and innovate at a faster pace. As a result, California continues to lead in medical technology advancements, improving healthcare outcomes worldwide.